Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis

Eur Heart J. 2017 May 14;38(19):1455-1462. doi: 10.1093/eurheartj/ehw454.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Acute Coronary Syndrome / drug therapy
  • Administration, Oral
  • Anticoagulants / administration & dosage
  • Atrial Fibrillation / drug therapy*
  • Cerebral Hemorrhage / chemically induced
  • Consensus
  • Coronary Artery Disease / drug therapy*
  • Drug Substitution
  • Fibrinolytic Agents / adverse effects*
  • Gastrointestinal Hemorrhage / chemically induced
  • Hemorrhage / chemically induced*
  • Humans
  • Percutaneous Coronary Intervention / adverse effects
  • Platelet Aggregation Inhibitors / adverse effects
  • Postoperative Complications / etiology
  • Risk Factors
  • Stents
  • Thrombosis / prevention & control
  • Vitamin K / antagonists & inhibitors

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Vitamin K